Brief: Idera Pharmaceuticals Reports First Quarter 2022 Financial Results
05/05/2022 21:47
May 5 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q1 LOSS PER SHARE $0.08
Source text for Eikon: ID:nGNX109RHL
Further company coverage: IDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary